Empagliflozin Prevent High-Glucose Stimulation Inducing Apoptosis and Mitochondria Fragmentation in H9C2 Cells through the Calcium-Dependent Activation Extracellular Signal-Regulated Kinase 1/2 Pathway
A previous study showed that high-glucose (HG) conditions induce mitochondria fragmentation through the calcium-mediated activation of extracellular signal-regulated kinase 1/2 (ERK 1/2) in H9C2 cells. This study tested whether empagliflozin could prevent HG-induced mitochondria fragmentation throug...
Saved in:
Published in | International journal of molecular sciences Vol. 25; no. 15; p. 8235 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
01.08.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A previous study showed that high-glucose (HG) conditions induce mitochondria fragmentation through the calcium-mediated activation of extracellular signal-regulated kinase 1/2 (ERK 1/2) in H9C2 cells. This study tested whether empagliflozin could prevent HG-induced mitochondria fragmentation through this pathway. We found that exposing H9C2 cells to an HG concentration decreased cell viability and increased cell apoptosis and caspase-3. Empagliflozin could reverse the apoptosis effect of HG stimulation on H9C2 cells. In addition, the HG condition caused mitochondria fragmentation, which was reduced by empagliflozin. The expression of mitochondria fission protein was upregulated, and fusion proteins were downregulated under HG stimulation. The expression of fission proteins was decreased under empagliflozin treatment. Increased calcium accumulation was observed under the HG condition, which was decreased by empagliflozin. The increased expression of ERK 1/2 under HG stimulation was also reversed by empagliflozin. Our study shows that empagliflozin could reverse the HG condition, causing a calcium-dependent activation of the ERK 1/2 pathway, which caused mitochondria fragmentation in H9C2 cells. |
---|---|
AbstractList | A previous study showed that high-glucose (HG) conditions induce mitochondria fragmentation through the calcium-mediated activation of extracellular signal-regulated kinase 1/2 (ERK 1/2) in H9C2 cells. This study tested whether empagliflozin could prevent HG-induced mitochondria fragmentation through this pathway. We found that exposing H9C2 cells to an HG concentration decreased cell viability and increased cell apoptosis and caspase-3. Empagliflozin could reverse the apoptosis effect of HG stimulation on H9C2 cells. In addition, the HG condition caused mitochondria fragmentation, which was reduced by empagliflozin. The expression of mitochondria fission protein was upregulated, and fusion proteins were downregulated under HG stimulation. The expression of fission proteins was decreased under empagliflozin treatment. Increased calcium accumulation was observed under the HG condition, which was decreased by empagliflozin. The increased expression of ERK 1/2 under HG stimulation was also reversed by empagliflozin. Our study shows that empagliflozin could reverse the HG condition, causing a calcium-dependent activation of the ERK 1/2 pathway, which caused mitochondria fragmentation in H9C2 cells. A previous study showed that high-glucose (HG) conditions induce mitochondria fragmentation through the calcium-mediated activation of extracellular signal-regulated kinase 1/2 (ERK 1/2) in H9C2 cells. This study tested whether empagliflozin could prevent HG-induced mitochondria fragmentation through this pathway. We found that exposing H9C2 cells to an HG concentration decreased cell viability and increased cell apoptosis and caspase-3. Empagliflozin could reverse the apoptosis effect of HG stimulation on H9C2 cells. In addition, the HG condition caused mitochondria fragmentation, which was reduced by empagliflozin. The expression of mitochondria fission protein was upregulated, and fusion proteins were downregulated under HG stimulation. The expression of fission proteins was decreased under empagliflozin treatment. Increased calcium accumulation was observed under the HG condition, which was decreased by empagliflozin. The increased expression of ERK 1/2 under HG stimulation was also reversed by empagliflozin. Our study shows that empagliflozin could reverse the HG condition, causing a calcium-dependent activation of the ERK 1/2 pathway, which caused mitochondria fragmentation in H9C2 cells.A previous study showed that high-glucose (HG) conditions induce mitochondria fragmentation through the calcium-mediated activation of extracellular signal-regulated kinase 1/2 (ERK 1/2) in H9C2 cells. This study tested whether empagliflozin could prevent HG-induced mitochondria fragmentation through this pathway. We found that exposing H9C2 cells to an HG concentration decreased cell viability and increased cell apoptosis and caspase-3. Empagliflozin could reverse the apoptosis effect of HG stimulation on H9C2 cells. In addition, the HG condition caused mitochondria fragmentation, which was reduced by empagliflozin. The expression of mitochondria fission protein was upregulated, and fusion proteins were downregulated under HG stimulation. The expression of fission proteins was decreased under empagliflozin treatment. Increased calcium accumulation was observed under the HG condition, which was decreased by empagliflozin. The increased expression of ERK 1/2 under HG stimulation was also reversed by empagliflozin. Our study shows that empagliflozin could reverse the HG condition, causing a calcium-dependent activation of the ERK 1/2 pathway, which caused mitochondria fragmentation in H9C2 cells. |
Audience | Academic |
Author | Wang, Hui-Ting Lee, Wen-Chin Liu, Wen-Hao Lin, Pei-Ting Hsueh, Shu-Kai Chen, Yung-Lung |
Author_xml | – sequence: 1 givenname: Yung-Lung orcidid: 0000-0001-7465-0880 surname: Chen fullname: Chen, Yung-Lung – sequence: 2 givenname: Hui-Ting surname: Wang fullname: Wang, Hui-Ting – sequence: 3 givenname: Wen-Chin orcidid: 0000-0001-6172-1483 surname: Lee fullname: Lee, Wen-Chin – sequence: 4 givenname: Pei-Ting orcidid: 0000-0002-8474-4976 surname: Lin fullname: Lin, Pei-Ting – sequence: 5 givenname: Wen-Hao surname: Liu fullname: Liu, Wen-Hao – sequence: 6 givenname: Shu-Kai surname: Hsueh fullname: Hsueh, Shu-Kai |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39125805$$D View this record in MEDLINE/PubMed |
BookMark | eNptkk1v1DAQhiNURD_gxhlZ4sKBtI6deJPjKmy7FUVUFM6R155kvXLsYDuF9h_2X-GQVpSq8mEs63nfmfHMYbJnrIEkeZvhY0orfKJ2vSdFVpSEFi-SgywnJMWYLfYe3feTQ-93GBNKiupVsk-rjBQlLg6Su1U_8E6rVttbZdClg2swAa1Vt03P9CisB3QVVD9qHpQ16NzIUSjToeVgh2C98ogbib6oYMXWGukUR6eOd310mRXRdV3VBNWgtUdh6-zYbWMEVHMt1Ninn2AAI6e0SxHU9Sxb_Q6Oi6iJmR26Up3hOv0G3VQISPRZGR5Ly04IuuRh-4vfvE5etlx7eHMfj5Ifp6vv9Tq9-Hp2Xi8vUpGTPKQZ28gccI454RSzospYu6BSMqAtg2qRi4IAZbQCRlrCCGBJC7apZMmpoOWGHiUfZt_B2Z8j-ND0yk-FcgN29A3F8XPLkpVVRN8_QXd2dLGRvxSucrog5B_VcQ2NMq2dOp9Mm2WJ8yKLYywjdfwMFY-EXom4Eq2K7_8J3t0nHzc9yGZwqufupnmYfQTIDAhnvXfQNkLNM4vOSjcZbqYFax4vWBR9fCJ68H0W_wNRtdK0 |
CitedBy_id | crossref_primary_10_1007_s11255_025_04443_z |
Cites_doi | 10.3390/antiox10081223 10.14814/phy2.13741 10.1089/ars.2010.3284 10.1016/j.biopha.2021.112455 10.1016/j.jacc.2019.11.031 10.1186/s12933-022-01532-6 10.3892/ijmm.2012.1186 10.3390/cells8091085 10.1007/s00125-018-4670-7 10.1152/ajprenal.00565.2018 10.3390/cells11193107 10.3390/ijms232213816 10.1056/NEJMoa2022190 10.1016/j.bbrc.2019.03.193 10.1038/s41598-020-76698-8 10.1002/advs.202100275 10.3389/fphys.2020.00252 10.1056/NEJMoa1811744 10.1016/j.diabres.2019.107843 10.1016/S0898-6568(02)00007-4 10.3390/ijms20071680 10.1056/NEJMoa1611925 10.1186/s12933-023-01756-0 10.1056/NEJMoa1504720 10.1007/s11886-019-1165-1 10.3389/fcvm.2022.859253 10.1111/jcmm.13975 10.1155/2022/1122494 10.1007/s10741-020-10024-2 10.1056/NEJMoa2024816 10.1002/jcp.27597 10.3389/fcvm.2023.1005408 10.1056/NEJMoa1515920 10.1007/s00125-019-05039-w 10.1016/j.metabol.2020.154334 10.3390/cells9071662 10.1016/j.cellsig.2019.109506 10.1046/j.1523-1755.1998.00868.x 10.1016/j.kint.2020.06.019 10.1038/s41569-020-0406-8 10.1124/pr.115.011502 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2024 MDPI AG 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: COPYRIGHT 2024 MDPI AG – notice: 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH K9. M0S M1P M2O MBDVC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI Q9U 7X8 |
DOI | 10.3390/ijms25158235 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection (ProQuest) Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Proquest Medical Database ProQuest research library Research Library (Corporate) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1422-0067 |
ExternalDocumentID | A804511428 39125805 10_3390_ijms25158235 |
Genre | Journal Article |
GeographicLocations | United States Taiwan |
GeographicLocations_xml | – name: Taiwan – name: United States |
GrantInformation_xml | – fundername: Kaohsiung Chang Gung Memorial Hospital grantid: CMRPG8K1391, CMRPG8K1392, CMRPG8K1393 |
GroupedDBID | --- 29J 2WC 53G 5GY 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ 8G5 A8Z AADQD AAFWJ AAHBH AAYXX ABDBF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV AEAQA AENEX AFKRA AFZYC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BPHCQ BVXVI CCPQU CITATION CS3 D1I DIK DU5 DWQXO E3Z EBD EBS EJD ESX F5P FRP FYUFA GNUQQ GUQSH GX1 HH5 HMCUK HYE IAO IHR ITC KQ8 LK8 M1P M2O M48 MODMG O5R O5S OK1 OVT P2P PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RNS RPM TR2 TUS UKHRP ~8M 3V. ABJCF BBNVY BHPHI CGR CUY CVF ECM EIF GROUPED_DOAJ HCIFZ KB. M7P M~E NPM PDBOC PMFND 7XB 8FK K9. MBDVC PJZUB PKEHL PPXIY PQEST PQUKI Q9U 7X8 |
ID | FETCH-LOGICAL-c424t-16bd4e040a2a3065916f73dd6e3f6e974c52e3639e62f262e0d356b9d8a3c38b3 |
IEDL.DBID | M48 |
ISSN | 1422-0067 1661-6596 |
IngestDate | Fri Jul 11 06:57:48 EDT 2025 Fri Jul 25 22:45:11 EDT 2025 Tue Jun 17 22:04:20 EDT 2025 Tue Jun 10 21:01:55 EDT 2025 Wed Feb 19 02:06:59 EST 2025 Tue Jul 01 01:43:42 EDT 2025 Thu Apr 24 22:57:28 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 15 |
Keywords | empagliflozin high-glucose stimulation H9C2 mitochondria fragmentation calcium-dependent extracellular signal-regulated kinase 1/2 |
Language | English |
License | https://creativecommons.org/licenses/by/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c424t-16bd4e040a2a3065916f73dd6e3f6e974c52e3639e62f262e0d356b9d8a3c38b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-7465-0880 0000-0001-6172-1483 0000-0002-8474-4976 |
OpenAccessLink | https://www.proquest.com/docview/3090943722?pq-origsite=%requestingapplication% |
PMID | 39125805 |
PQID | 3090943722 |
PQPubID | 2032341 |
ParticipantIDs | proquest_miscellaneous_3091288689 proquest_journals_3090943722 gale_infotracmisc_A804511428 gale_infotracacademiconefile_A804511428 pubmed_primary_39125805 crossref_citationtrail_10_3390_ijms25158235 crossref_primary_10_3390_ijms25158235 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-08-01 |
PublicationDateYYYYMMDD | 2024-08-01 |
PublicationDate_xml | – month: 08 year: 2024 text: 2024-08-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | International journal of molecular sciences |
PublicationTitleAlternate | Int J Mol Sci |
PublicationYear | 2024 |
Publisher | MDPI AG |
Publisher_xml | – name: MDPI AG |
References | Yu (ref_17) 2011; 14 ref_36 ref_13 Zinman (ref_3) 2015; 373 Margonato (ref_12) 2021; 26 Cowie (ref_15) 2020; 17 ref_11 ref_10 ref_32 ref_31 Wanner (ref_4) 2016; 375 Lee (ref_18) 2019; 317 ref_19 Packer (ref_30) 2020; 383 Smogorzewski (ref_37) 1998; 53 ref_39 ref_38 Yang (ref_28) 2019; 513 Zelniker (ref_14) 2020; 75 Buse (ref_8) 2020; 63 Szepes (ref_40) 2013; 31 Verma (ref_16) 2018; 61 Heerspink (ref_5) 2020; 383 ref_25 ref_24 ref_23 ref_22 Suliman (ref_35) 2016; 68 ref_20 ref_41 ref_1 Perkovic (ref_7) 2019; 380 Tahrir (ref_34) 2019; 234 ref_2 ref_29 Agell (ref_21) 2002; 14 ref_27 Liu (ref_33) 2019; 23 ref_26 ref_9 Neal (ref_6) 2017; 377 |
References_xml | – ident: ref_41 doi: 10.3390/antiox10081223 – ident: ref_32 doi: 10.14814/phy2.13741 – volume: 14 start-page: 425 year: 2011 ident: ref_17 article-title: High-glucose stimulation increases reactive oxygen species production through the calcium and mitogen-activated protein kinase-mediated activation of mitochondrial fission publication-title: Antioxid. Redox Signal. doi: 10.1089/ars.2010.3284 – ident: ref_22 doi: 10.1016/j.biopha.2021.112455 – volume: 75 start-page: 422 year: 2020 ident: ref_14 article-title: Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors: JACC State-of-the-Art Review publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2019.11.031 – ident: ref_31 doi: 10.1186/s12933-022-01532-6 – volume: 31 start-page: 26 year: 2013 ident: ref_40 article-title: Pretreatment of therapeutic cells with poly(ADP-ribose) polymerase inhibitor enhances their efficacy in an in vitro model of cell-based therapy in myocardial infarct publication-title: Int. J. Mol. Med. doi: 10.3892/ijmm.2012.1186 – ident: ref_10 doi: 10.3390/cells8091085 – volume: 61 start-page: 2108 year: 2018 ident: ref_16 article-title: SGLT2 inhibitors and mechanisms of cardiovascular benefit: A state-of-the-art review publication-title: Diabetologia doi: 10.1007/s00125-018-4670-7 – volume: 317 start-page: F767 year: 2019 ident: ref_18 article-title: Empagliflozin attenuates diabetic tubulopathy by improving mitochondrial fragmentation and autophagy publication-title: Am. J. Physiol. Renal Physiol. doi: 10.1152/ajprenal.00565.2018 – ident: ref_23 doi: 10.3390/cells11193107 – ident: ref_27 doi: 10.3390/ijms232213816 – volume: 383 start-page: 1413 year: 2020 ident: ref_30 article-title: Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2022190 – volume: 513 start-page: 154 year: 2019 ident: ref_28 article-title: High-glucose induces cardiac myocytes apoptosis through Foxo1/GRK2 signaling pathway publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2019.03.193 – ident: ref_39 doi: 10.1038/s41598-020-76698-8 – ident: ref_1 doi: 10.1002/advs.202100275 – ident: ref_36 doi: 10.3389/fphys.2020.00252 – volume: 380 start-page: 2295 year: 2019 ident: ref_7 article-title: Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1811744 – ident: ref_2 doi: 10.1016/j.diabres.2019.107843 – volume: 14 start-page: 649 year: 2002 ident: ref_21 article-title: Modulation of the Ras/Raf/MEK/ERK pathway by Ca2+, and calmodulin publication-title: Cell Signal. doi: 10.1016/S0898-6568(02)00007-4 – ident: ref_38 doi: 10.3390/ijms20071680 – volume: 377 start-page: 644 year: 2017 ident: ref_6 article-title: Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1611925 – ident: ref_20 doi: 10.1186/s12933-023-01756-0 – volume: 373 start-page: 2117 year: 2015 ident: ref_3 article-title: Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1504720 – ident: ref_13 doi: 10.1007/s11886-019-1165-1 – ident: ref_25 doi: 10.3389/fcvm.2022.859253 – volume: 23 start-page: 798 year: 2019 ident: ref_33 article-title: Vildagliptin improves high glucose-induced endothelial mitochondrial dysfunction via inhibiting mitochondrial fission publication-title: J. Cell Mol. Med. doi: 10.1111/jcmm.13975 – ident: ref_19 doi: 10.1155/2022/1122494 – volume: 26 start-page: 337 year: 2021 ident: ref_12 article-title: Renal protection: A leading mechanism for cardiovascular benefit in patients treated with SGLT2 inhibitors publication-title: Heart Fail. Rev. doi: 10.1007/s10741-020-10024-2 – volume: 383 start-page: 1436 year: 2020 ident: ref_5 article-title: Dapagliflozin in Patients with Chronic Kidney Disease publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2024816 – volume: 234 start-page: 8122 year: 2019 ident: ref_34 article-title: Mitochondrial quality control in cardiac cells: Mechanisms and role in cardiac cell injury and disease publication-title: J. Cell Physiol. doi: 10.1002/jcp.27597 – ident: ref_26 doi: 10.3389/fcvm.2023.1005408 – volume: 375 start-page: 323 year: 2016 ident: ref_4 article-title: Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1515920 – volume: 63 start-page: 221 year: 2020 ident: ref_8 article-title: 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) publication-title: Diabetologia doi: 10.1007/s00125-019-05039-w – ident: ref_11 doi: 10.1016/j.metabol.2020.154334 – ident: ref_29 doi: 10.3390/cells9071662 – ident: ref_24 doi: 10.1016/j.cellsig.2019.109506 – volume: 53 start-page: 1237 year: 1998 ident: ref_37 article-title: High glucose concentration causes a rise in [Ca2+]i of cardiac myocytes publication-title: Kidney Int. doi: 10.1046/j.1523-1755.1998.00868.x – ident: ref_9 doi: 10.1016/j.kint.2020.06.019 – volume: 17 start-page: 761 year: 2020 ident: ref_15 article-title: SGLT2 inhibitors: Mechanisms of cardiovascular benefit beyond glycaemic control publication-title: Nat. Rev. Cardiol. doi: 10.1038/s41569-020-0406-8 – volume: 68 start-page: 20 year: 2016 ident: ref_35 article-title: Mitochondrial Quality Control as a Therapeutic Target publication-title: Pharmacol. Rev. doi: 10.1124/pr.115.011502 |
SSID | ssj0023259 |
Score | 2.4365628 |
Snippet | A previous study showed that high-glucose (HG) conditions induce mitochondria fragmentation through the calcium-mediated activation of extracellular... |
SourceID | proquest gale pubmed crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 8235 |
SubjectTerms | Animals Antidiabetics Apoptosis Apoptosis - drug effects Benzhydryl Compounds - pharmacology Blood vessels Calcium - metabolism Caspase 3 - metabolism Cell Line Cell Survival - drug effects Dextrose Diabetes Glucose Glucose - metabolism Glucosides - pharmacology Kidneys Kinases MAP Kinase Signaling System - drug effects Mitochondria Mitochondria - drug effects Mitochondria - metabolism Mitochondrial Dynamics - drug effects Mitogen-Activated Protein Kinase 1 - metabolism Mitogen-Activated Protein Kinase 3 - metabolism Oxidative stress Proteins Quantitative analysis Rats Scientific equipment and supplies industry Type 2 diabetes |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nj9MwELVgERIXxDdZFmQkEAdkNbUdJzmhqnSpQIsQy0q9RY7tVEFpUjapluUf8q-YSdyWXQlOOdiJkoxn5k38Mo-QV1BtKRMWisVJETPpQsO0k4oZaVSexyaV_XbByWc1P5MfF9HCf3BrPa1yGxP7QG0bg9_IRyJMkQQXc_5u_YOhahTurnoJjZvkFrYuQ0pXvNgXXIL3YmljyEFMRakaiO8CyvxR-X3VQmqPEt4Lve1T0vXAfA1u9mnn-B656_EinQwGvk9uuPoBuT0oSF4-JL9n4M7Lqiyq5ldZU9-QiSJ7g30Y2Oj0tCtXXqSLolKHgWxFJ-tm3TVt2VJdW3oCfg1xsLawHClg2eXK_5JUU7jqPJ1yOnVV1VIv6wNHR6e6MuVmxd57Hd2OTsxWLI3OfnbnGncFkOZKT8slPAX7OgjfO0s_lTWkTzoecfoFMOiFvnxEzo5n36Zz5tUZwI5cdmyscgu2laHmGuXnAWcWsbBWOVEoB2WKibgTAICc4gVX3IVWRCpPbaKFEUkuHpODuqndU0JNONZGFTK1-aBoKQstk8JEGCDA6AF5uzVQZnzrclTQqDIoYdCc2d_mDMjr3ez10LLjH_PeoK0z9GR8Jdr_kAD3hD2xskmCvXewI11Ajq7MBA80V4e3qyXzEaDN9us1IC93w3gmstpq12z6OQAPEpWkAXkyrLLdHQsYipIwOvz_xZ-ROxxg1kBJPCIH3fnGPQeY1OUvel_4Ax5OEm4 priority: 102 providerName: ProQuest |
Title | Empagliflozin Prevent High-Glucose Stimulation Inducing Apoptosis and Mitochondria Fragmentation in H9C2 Cells through the Calcium-Dependent Activation Extracellular Signal-Regulated Kinase 1/2 Pathway |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39125805 https://www.proquest.com/docview/3090943722 https://www.proquest.com/docview/3091288689 |
Volume | 25 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lj9MwELb2ISQuiDeBpTISiAMKm9qOkxwQKqXdCtTVapdKvUWO41RBaVKaVGz5h_wrZvKo6AISl-RgJ7I9M55v4sl8hLyEaEtqJ5G25yeeLYyjbWWEtLXQMoo8HYj6uGB6Licz8Wnuzg9IxzbaLmD519AO-aRm6-zt9bftezD4dxhxQsh-mn5dluCmXZ9x95Acg0_y0ESnYneeALChpk3DDx42btBNCvwfT-85p5tb9A3gWTug8V1yp0WOdNCI-h45MPl9cqvhktw-ID9HYNiLLE2y4kea07Y0E8U8DvusyUunV1W6bOm6KHJ2aPBbdLAqVlVRpiVVeUynYOGwKHkMikkB1S6W7c9JOYW3ToIho0OTZSVtCX7gbuhQZTrdLO2PLaNuRQe6o02jo-tqrfB8ABNe6VW6gFnYl2aBAzEx_Zzm4Ehp_5TRC0Cj39X2IZmNR1-GE7vlaQCJMlHZfRnFIGXhKKaQiB4QZ-LxOJaGJ9JAwKJdZjhAISNZwiQzTsxdGQWxr7jmfsQfkaO8yM0TQrXTV1omIoijhttSJEr4iXZxqwgEt8ibTkChbouYI5dGFkIwg-IMfxenRV7teq-a4h3_6PcaZR2iluGSqPbXBBgTVscKBz5W4cHadBY52esJtqj3mzttCTtVDrkTYPqmx5hFXuya8UnMb8tNsan7AFDwpR9Y5HGjZbsRc2hyfcd9-p-zeUZuM0BeTZbiCTmq1hvzHJBTFfXIoTf34OqPz3rk-MPo_OKyh77M7dXm8guP7hwT |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbGEIIXxJ2OAUZi4gFZTe3ESR4QqrqOjq4TYpvUt-A4TpUpTcqSapQfxf_gX3FOLi2bBG97yoMdx8m5fY6Pz0fIW1htSW3Fkrle7DLbWJopY0umbS3D0NW-XW0XTI7l6Mz-PHWmW-RXexYG0ypbn1g56ijX-I-8Kywfk-Bczj8uvjNkjcLd1ZZCo1aLsVldwpKt-HC4D_Ld4_xgeDoYsYZVAJ7P7ZL1ZBjBnGxLcYW06YCPYldEkTQilgbgtXa4ERC4jeQxl9xYkXBk6EeeElp4oYBxb5HbEHgttCh3ulngCV6Rs_Ug5jEYWNaJ9kL4Vjc5nxcAJRyPV8RymxB4PRBcg7dVmDt4QO43-JT2a4V6SLZM9ojcqRkrV4_J7yG4j1maxGn-M8loUwCKYrYI-1Rnv9OTMpk3pGAUmUE0REfaX-SLMi-SgqosohPwI-B3swjUnwJ2ns2bI1AZhVFH_oDTgUnTgjY0QnA1dKBSnSznbL_h7S1pX7fkbHT4o7xQuAuBabX0JJnBW7CvZoYTMREdJxmEa9rrcvoFMO-lWj0hZzcit6dkO8sz85xQbfWUlrHtR2HNoGnHyvZi7aBDAiXrkPetgALdlEpHxo40gCUTijP4W5wdsrfuvahLhPyj3zuUdYCeAz-Jag5AwJywBlfQ97DWD1bA65DdKz3B4vXV5lZbgsbjFMHGPjrkzboZ78Qsuszky6oPwBFPen6HPKu1bD1jAU2OZzk7_x_8Nbk7Op0cBUeHx-MX5B4HiFenQ-6S7fJiaV4CRCvDV5VdUPLtpg3xD5MvTlM |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbGEIgXxJ3CACMx8YCspnbiJA8IVb3QUTZNjEl9yxLHqYLSpCypRvlp_AP-FeckTssmwdue8mDXOum5fY6Pz0fIG9htSWUlkrle4jJbW4qF2pZM2UpGkat8uz4uODySk1P708yZ7ZBf7V0YLKtsY2IdqONC4TfyrrB8LIJzOe8mpizieDj-sPzOkEEKT1pbOo3GRKZ6fQHbt_L9wRB0vc_5ePR1MGGGYQBk4XbFejKKQT7bCnmIFOqAlRJXxLHUIpEaoLZyuBaQxLXkCZdcW7FwZOTHXiiU8CIB694gN13h9NDH3Nl2syd4TdTWg_zHYGHZFN0L4Vvd9NuiBFjheLwmmdumw6tJ4QrUrVPe-B65a7Aq7TfGdZ_s6PwBudWwV64fkt8jCCXzLE2y4meaU9MMimLlCPvYVMLTkypdGIIwiiwhCjIl7S-LZVWUaUnDPKaHEFMgBucxuAIFHD1fmOtQOYVVJ_6A04HOspIaSiF4ajoIM5WuFmxoOHwr2lctURsd_ajOQzyRwBJbepLO4S3YFz1HQXRMp2kOqZv2upweA_69CNePyOm16O0x2c2LXD8lVFm9UMnE9uOoYdO0k9D2EuVgcAKD65B3rYICZdqmI3tHFsD2CdUZ_K3ODtnfzF427UL-Me8t6jrAKIJ_SWguQ4BM2I8r6HvY9we74XXI3qWZ4P3q8nBrLYGJPmWw9ZUOeb0Zxl9iRV2ui1U9B6CJJz2_Q540VraRWMCQ41nOs_8v_orcBhcMPh8cTZ-TOxzQXlMZuUd2q_OVfgForYpe1m5Bydl1--EfHLNSiQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Empagliflozin+Prevent+High-Glucose+Stimulation+Inducing+Apoptosis+and+Mitochondria+Fragmentation+in+H9C2+Cells+through+the+Calcium-Dependent+Activation+Extracellular+Signal-Regulated+Kinase+1%2F2+Pathway&rft.jtitle=International+journal+of+molecular+sciences&rft.au=Chen%2C+Yung-Lung&rft.au=Wang%2C+Hui-Ting&rft.au=Lee%2C+Wen-Chin&rft.au=Lin%2C+Pei-Ting&rft.date=2024-08-01&rft.issn=1422-0067&rft.eissn=1422-0067&rft.volume=25&rft.issue=15&rft.spage=8235&rft_id=info:doi/10.3390%2Fijms25158235&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_ijms25158235 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1422-0067&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1422-0067&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1422-0067&client=summon |